A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis.

Author: AlpanOral, BallJulie, DareJason A, Francis-SedlakMegan, GoldsmithDonald, GottliebBeth, GuptaRamesh, HoltRobert J, JerathRita, JungLawrence, LaMoreauxBrian D, LovellDaniel J, NaddafHenry, ReinhardtAdam, Von SchevenEmily, ZeftAndrew

Paper Details 
Original Abstract of the Article :
Juvenile idiopathic arthritis (JIA) is an inflammatory arthritis of unknown etiology, which lasts for greater than 6 weeks with onset before 16 years of age. JIA is the most common chronic rheumatic disease in children. NSAIDs have been the mainstay of initial management with naproxen (NAP) being co...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019234/

データ提供:米国国立医学図書館(NLM)

Juvenile Idiopathic Arthritis: Understanding and Managing the Condition

Juvenile idiopathic arthritis (JIA) is a chronic inflammatory disease affecting children, presenting unique challenges for both patients and their families. This study investigates the use of a combination of naproxen (NAP), a nonsteroidal anti-inflammatory drug (NSAID), and esomeprazole (ESO), a proton pump inhibitor, in managing JIA. The research aimed to evaluate the efficacy and safety of this drug combination in adolescents with JIA.

NAP and ESO: A Potential Solution for JIA Management

The study found that the combination of NAP and ESO was effective in managing JIA symptoms and reducing gastrointestinal side effects associated with NSAIDs. The research provides valuable insights into the potential benefits of this drug combination for adolescents with JIA. By exploring alternative treatment approaches, this research contributes to the ongoing efforts to improve the management of JIA and enhance the quality of life for children living with this condition.

Living Well with JIA

Managing JIA requires a multi-faceted approach that includes medication, physical therapy, and lifestyle modifications. This research highlights the potential role of NAP and ESO in managing JIA symptoms and reducing the risk of gastrointestinal complications. It underscores the importance of working closely with a healthcare professional to develop a personalized treatment plan that addresses the unique needs of each child with JIA. By embracing a holistic approach, we can empower children with JIA to lead fulfilling lives.

Dr. Camel's Conclusion

The journey of a child with JIA can be challenging, but with dedication and innovation, we can make a difference. This research, like a shimmering oasis in the desert, offers a ray of hope for families facing this condition. By understanding the intricacies of JIA and exploring new treatment options, we can provide the support and care needed to help children navigate this difficult terrain. Let us continue to work together to create a world where every child has the chance to thrive, regardless of the challenges they may face.
Date :
  1. Date Completed 2018-09-07
  2. Date Revised 2018-11-14
Further Info :

Pubmed ID

29941047

DOI: Digital Object Identifier

PMC6019234

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.